Ukrainian pharmaceutical company Lekhim, the partner of Sinovac Biotech company asked the Ukrainian government to let it delay the supply of first batches of the Chinese vaccine from April. Reuters reported that on February 9.
Lekhim cites delays with obtaining the export license from Chinese government and late Ukrainian Parliament's approval of the law on registration of vaccines.
"This resulted in the delay of the approval of the schedule of supplies between Lekhim and Sinovac Biotech, and re-scheduling the deadline of the vaccine supply in Ukraine", reads the message.
The company also added it would like to change the way of definition of the established index of the vaccine efficiency, which makes 70 percent. However, Lekhim did not specify it in its request about the delay.
The vaccination program in Ukraine has been falling behind similar programs in other European countries, and the delay could lead to increasing health risks.
In December 2020, Ukraine's Healthcare Ministry signed the contract with Sinovac, agreeing to shiplement of 1.9 million doses of vaccine from Covid-19.